Table 1.
Characteristics | OCD |
HC |
---|---|---|
n |
n |
|
Mean ± SD | Mean ± SD | |
Sample size | 66 | 66 |
Female | 46 (69.7%) | 46 (69.7%) |
Age (years) | 32.4 ± 10.5 | 31.6 ± 10.3‡ |
Disease duration | 16.0 ± 10.8 | |
Y-BOCS total | 21.0 ± 6.2 | |
Obsession | 11.0 ± 3.6 | |
Compulsions | 9.9 ± 3.9 | |
OCI-R total | 25.4 ± 10.0 | |
Hoarding | 2.3 ± 2.6 | |
Checking | 5.5 ± 3.6 | |
Ordering | 3.9 ± 3.8 | |
Neutralizing | 2.2 ± 2.9 | |
Washing | 4.8 ± 3.9 | |
Obsessing | 6.8 ± 3.6 | |
BDI (S1) | 18.0 ± 11.5 | |
HAM-D (S2) | 12.6 ± 4.9 | |
Comorbidities | 30 (45.5%) | |
Depression | 23 | |
Anxiety disorder | 10 | |
Personality disorder | 4 | |
Eating disorder | 2 | |
ADHD | 2 | |
Medication | 48 (72.7%) | |
SSRI | 35 | |
SSRNI | 6 | |
Neuroleptic | 5 | |
TCA | 3 | |
Methylphenidate | 1 | |
Benzodiazepine | 1 | |
NDRI | 1 | |
NaSSA | 1 |
Note that multiple comorbid diagnoses as well as different medication types can be present in a single patient; abbreviations for medication: NaSSA, noradrenergic and specific serotonergic antidepressant; NDRI, norepinephrine-dopamine reuptake inhibitor; SSNRI, selective serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.
Two-sample t-test (t(130) = 0.442, p = 0.659).